Dr. Jay Bishoff presented his poster titled “The CCP Score Provides Significant Prognostic Information in Gleason Score < 6 Patients” during AUA 2016 in San Diego, California. The study found that Prolaris predicts oncologic outcomes in patients with a Gleason score of < 6. If you weren’t able to attend, you can view Dr. Bishoff’s presentation of the poster in this video.
In conclusion, it was determined that the cell cycle progression score (CCP) otherwise known as the Prolaris Score, was associated with adverse outcomes following surgery. With these results, the score can be used during diagnosis to better determine a patients prognosis and what treatment path should be taken.
Learn more about the results from Dr. Jay Bishoff in The Journal of Urology.